Evidence map›Paper›PMID 33123953›Full record

ArticleTranslational stroke research2021

Correction to: Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type.

Shirin Z Birjandi, Nora Abduljawad, Shyama Nair, Morteza Dehghani, Kazunori Suzuki, Haruhide Kimura, S Thomas Carmichael

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational stroke research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Shirin Z BirjandiDepartments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
Nora AbduljawadDepartments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
Shyama NairDepartments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
Morteza DehghaniDepartments of Psychology and of Computer Science, University of Southern California, Los Angeles, CA, USA.
Kazunori SuzukiNeuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
Haruhide KimuraNeuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
S Thomas CarmichaelDepartments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA. scarmich@g.ucla.edu.ORCID https://orcid.org/0000-0002-1169-9203

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33123953
PMCPMC8213669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.